Harvard 3rd Annual Update in Neuro-Oncology 2023

Neuro-oncology is a rapidly evolving multi-disciplinary field, which involves the medical, radiation and surgical management of pediatric and adult patients with primary and metastatic tumors of the central nervous system (CNS) and peripheral nervous system (PNS). In addition, modern molecular neuropathology and neuroradiology concepts are essential for accurate diagnosis and classification. This three-day course, Annual Update in Neuro-Oncology, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors and neurological complications of cancer. Our target audience will be the providers involved in the care of adult and pediatric neuro-oncology patients (oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists and neuropathologists). The course will also be of high relevance to nurse practitioners, physician assistants, psychologists, pharmacists and nurses.
Who Should Attend

Specialty Physicians
Nurses, Pharmacists
Physician Assistants
Psychologists

Learning Objectives
Upon completion of this activity, participants will be able to:

Identify the role of biomarkers in the diagnosis of pediatric and adult CNS and PNS tumors.
Identify standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
Recognize and address neurological complications associated with new cancer therapies.
Identify and manage long-term complications of CNS and PNS tumors and their treatment.

The Harvard 3rd Annual Update in Neuro-Oncology 2023 is best for neurologists, oncologists, neurosurgeons, radiation oncologists, pathologists, and other healthcare professionals involved in the care of patients with central and peripheral nervous system tumors. It’s ideal for:
Who Should Attend

Clinicians treating primary and metastatic brain and spine tumors
Specialists managing neurological complications of cancer
Researchers and educators seeking updates on molecular neuropathology and neuroradiology

Dates: July 26–28, 2023
 
+ Topics:

Wednesday, July 26, 2023

10:00-10:10 AM Welcome: Pediatric Neuro-Oncology Session Mariella Filbin, MD, PhD

10:10-10:40 AM Keynote: CAR T Cell Therapy for Diffuse Midline Gliomas Michelle Monje,  MD, PhD

10:40-11:10 AM WHO Classification, Pediatric CNS Tumors Sanda Alexandrescu, MD

11:10-11:40 AM Embryonal Tumors Scott Pomeroy, MD, PhD

11:40 AM-12:00 PM Break

12:00-12:30 PM Pediatric Low-Grade Gliomas Susan Chi, MD

12:30-1:00 PM Pediatric High-Grade Gliomas Mariella Filbin, MD, PhD

1:00-1:30 PM Ependymomas and Glioneuronal Tumors Pratiti (Mimi) Bandopadhayay, MBBS, PhD

1:30-1:45 PM Live Question & Answer Session Mariella Filbin, MD, PhD

1:45-2:00 PM Break

2:00-2:15 PM Choroid Plexus Tumors Viviana Benitez, MD

2:15-2:30 PM Pineal Tumors Shannon MacDonald, MD

2:30-2:45 PM Germ Cell Tumors Aaron Yeo, MD

2:45-3:15 PM Neurofibromatosis Scott Plotkin, MD, PhD

3:15-3:30 PM Von Hippel Lindau Othon Iliopoulos, MD, PhD

3:30-3:45 PM Live Question & Answer Session Mariella Filbin, MD, PhD

3:45-3:50 PM Adjourn Mariella Filbin, MD, PhD

Thursday, July 27, 2023

10:00-10:05 AM Welcome: Adult Neuro-Oncology Tracy Batchelor, MD

10:05-10:30 AM Keynote: Surgical Immunotherapy Clinical Trials for Glioblastoma Multiforme (GBM) E. Antonio Chiocca, MD,PhD

10:30-10:45 AM Advances in Surgery for Brain Tumors William Curry, MD

10:45-11:00 AM Advances in Imaging for Brain Tumors Tina Young Poussaint, MD

11:00-11:15 AM Advances in Radiation for Brain Tumors Helen Shih, MD

11:15-11:25 AM Live Question and Answer Session Tracy Batchelor, MD

11:25-11:30 AM Break

11:30 AM-12:00 PM WHO Classification for Adult Gliomas David Louis, MD

12:00-12:30 PM Gliomas, IDH-Mutant ​​​​​Nicolas Gonzalez Castro, MD, PhD

12:30-12:45 PM Gliomas, IDH-Wildtype Isabel Arrillaga,  MD, PhD

12:45-1:10 PM Advances in Experimental Therapies for Gliomas David Reardon, MD

1:10-1:30 PM Break

1:30-1:45 PM Meningioma Wenya Linda Bi, MD, PhD

1:45-2:00 PM CNS Lymphomas Lakshmi Nayak, MD

2:00-2:15 PM Pituitary Tumors Pamela Jones, MD

2:15-2:45 PM Live Question & Answer Session Tracy Batchelor, MD

2:45-2:50 PM Adjourn

Friday, July 28, 2023

10:00-10:05 AM Welcome: Neurological Complications of Cancer Patrick Wen, MD

10:05-10:30 AM Keynote: Neural Regulation of Cancer Humsa Venkatesh, PhD

10:30-11:00 AM Metastases to the Brain Priscilla Brastianos, MD

11:00-11:15 AM Metastases to the Leptomeninges Ricky McFaline-Figueroa, MD, PhD

11:15-11:30 AM Metastases to the Epidural Space and Spinal Cord John Chi, MD, MPH

11:30-11:45 AM Live Question and Answer Session Patrick Wen, MD
11:45 AM-12:15 PM Break
12:15-12:30 PM Paraneoplastic Neurological Syndromes Eudocia Lee, MD, MPH

12:30-1:00 PM Common Neurological Complications in Cancer Patients Ugonma Chukwueke, MD, MPH

1:00-1:15 PM Neurological Complications of Cancer Immunotherapies Jorg Dietrich, MD, PhD

1:15-1:30 PM Managing Long-Term Survivors of CNS Tumors Deborah Forst, MD

1:30 – 1:45 PM Live Question and Answer Session Patrick Wen, MD

1:45-2:00 PM Closing & Adjourn Tracy Batchelor, MD, MPH